Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-002142
Filing Date
2019-01-29
Accepted
2019-01-29 18:55:36
Documents
1
Period of Report
2019-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4019
  Complete submission text file 0000899243-19-002142.txt   5451
Mailing Address C/O SOLIGENIX, INC. 29 EMMONS DRIVE, STE. C-10 PRINCETON NJ 08540
Business Address
HORGAN KEVIN (Reporting) CIK: 0001510614 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 19549931

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations